Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid

Vaccine

Volumn 18, Issue 13, 2000, Pages 1218-1226

  Korkeila, Maija ^a   Lehtonen, Hannele ^a   Åhman, Heidi ^a   Leroy, Odile ^b   Eskola, Juhani ^a   Käyhty, Helena ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b Pasteur Merieux Connaught   (France)

Author keywords

Conjugate vaccines; Salivary antibodies; Streptococcus pneumoniae

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN A ANTIBODY; INACTIVATED VIRUS VACCINE; MEASLES MUMPS RUBELLA VACCINE; ORAL POLIOMYELITIS VACCINE; PLACEBO; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE;

ANTIBODY TITER; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; ENZYME IMMUNOASSAY; HUMAN; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALIVA ANALYSIS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TETANUS; VACCINATION;

ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; DIPHTHERIA TOXOID; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; INFANT; POLYSACCHARIDES, BACTERIAL; SALIVA; STREPTOCOCCUS PNEUMONIAE; TETANUS TOXOID; VACCINES, CONJUGATE;

EID: 0033987277     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00393-X     Document Type: Article

References (46)

1. Käyhty H., Åhman H., Rönnberg P.-R., Tillikainen R., Eskola J. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. J. Infect. Dis. 172:1995;1273-1278.
2. Anderson E.L., Kennedy D.J., Geldmacher K.M., Donnelly J., Mendelman P.M. Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants. J. Pediatr. 128:1996;649-653.
3. Åhman H., Käyhty H., Tamminen P., Vuorela A., Malinoski F., Eskola J. Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants. Pediatr. Infect. Dis. J. 15:1996;134-139.
4. 197 vaccine: effect of saccharide size on immunogenicity and interactions with simultaneously administered vaccines. J. Infect. Dis. 176:1997;445-455.
5. Obaro S.K., Huo Z., Banya W.A., Henderson D.C., Monteil M.A., Leach A., Greenwood B.M. A glycoprotein pneumococcal conjugate vaccine primes for antibody responses to a pneumococcal polysaccharide vaccine in Gambian children. Pediatr. Infect. Dis. J. 16:1997;1135-1140.
6. Sigurdardottir S.T., Vidarsson G., Gudnason T., Kjartansson S., Kristinsson K.G., Steinn J., Valdimarsson H., Schiffman G., Schneerson R., Jonsdottir I. Immune responses of infants vaccinated with serotype 6B pneumococcal polysaccharide conjugated with tetanus toxoid. Pediatr. Infect. Dis. J. 16:1997;667-674.
7. Åhman H., Käyhty H., Lehtonen H., Leroy O., Froeschle J., Eskola J. Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory. Pediatr. Infect. Dis. J. 17:1998;211-216.
8. Åhman H, Käyhty H, Vuorela A, Leroy O, Eskola J, Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid, Vaccine 1999;17:2726-32.
9. Takala A.K., Eskola J., Leinonen M., Käyhty H., Nissinen A., Pekkanen E., Mäkelä P.H. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J. Infect. Dis. 164:1991;982-986.
10. Takala A.K., Santosham M., Almeido-Hill J., Wolff M., Newcome W., Reid R., Käyhty H., Esko E., Mäkelä P.H. Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children. Pediatr Infect. Dis. J. 12:1993;593-599.
11. Murphy T.V., Pastor P., Medley F., Osterholm M.T., Granoff D.M. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J. Pediatr. 122:1993;517-523.
12. Mohle-Boetani J.C., Ajello G., Breneman E., Deaver K.A., Harvey C., Plikaytis B.D., Farley M.M., Stephens D.S., Wenger J.D. Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines. Pediatr. Infect. Dis. J. 12:1993;589-593.
13. Barbour M.L., Booy R., Crook D.W., Griffiths H., Chapel H.M., Moxon E.R., Mayon-White D. Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine. Pediatr. Infect. Dis. J. 12:1993;478-484.
14. Barbour M.L., Mayon-White R.T., Coles C., Crook D.W.M., Moxon E.R. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J. Infect. Dis. 171:1995;93-98.
15. Kauppi M., Eskola J., Käyhty H. Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines. Pediatr. Infect. Dis. J. 14:1995;286-294.
16. Kauppi-Korkeila M., Saarinen L., Eskola J., Käyhty H. Subclass distribution of saliva and serum IgA after immunization with Haemophilus influenzae type b conjugate vaccines. Clin. Exp. Immunol. 111:1998;237.
17. Kauppi M., Saarinen L., Käyhty H. Anti-capsular polysaccharide antibodies reduce nasopharyngeal colonization by Haemophilus influenzae type b in infant rats. J. Infect. Dis. 167:1993;365-371.
18. Kauppi-Korkeila M., van Alphen L., Madore D., Käyhty H. Mechanism of antibody mediated reduction of nasopharyngeal colonization by Haemophilus influenzae type b studied in an infant rat model. J. Infect. Dis. 174:1996;1337-1340.
19. Obaro S.K., Adegbola R.A., Banya W.A.S., Greenwood B.M. Carriage of pneumococci after pneumococcal vaccination (letter). Lancet. 348:1996;271-272.
20. Dagan R., Melamed R., Muallem M., Piglansky L., Greenberg D., Abramson O., Mendelman P.M., Bohidar N., Yagupsy P. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J. Infect. Dis. 174:1996;1271-1278.
21. Dagan R., Muallem M., Melamed R., Leroy O., Yagupsky P. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. Pediatr. Infect. Dis. J. 16:1997;1060-1064.
22. Mbelle N., Wasas A., Huebner R., Kimura A., Chang I., Klugman K. Immunogenicity and impact on carriage of 9-valent pneumococcal conjugate vaccine given to infants in Soweto, South Africa. Programs and Abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). 1997;13 American Society for Microbiology, California.
23. Kristinsson K.G., Sigurdardottir S.T., Gudnason T.H., Kjartansson S., Davidsdottir K., Leroy O., Jonsdottir I. Effect of vaccination with octavalent conjugated pneumococcal vaccines on pneumococcal carriage in infants. Programs and Abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). 1997;193 American Society for Microbiology, California.
24. Shurin P.A., Rehmus J.M., Johnson C.E., Marchant C.D., Carlin S.A., Super D.M., Van Hare G.F., Jones P.K., Ambrosino D.M., Siber G.R. Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children. J. Pediatr. 123:1993;801-810.
25. Ishizaka A., Sakiyama Y., Makoto O., Ozutsumi K., Matsumoto S. Successful intravenous immunoglobulin therapy for recurrent pneumococcal otitis media in young children. Eur. J. Pediatr. 153:1994;174-178.
26. Giebink G.S., Meier J.D., Quartey M.K., Liebeler C.L., Le C.T. Immunogenicity and efficacy of Streptococcus pneumoniae polysaccharide-protein conjugate vaccines against homologous and heterologous serotypes in the chinchilla otitis media model. J. Infect. Dis. 173:1996;119-127.
27. Virolainen A., Jero J., Käyhty H., Karma P., Leinonen M., Eskola J. Nasopharyngeal antibodies to pneumococcal capsular polysaccharides in children with acute otitis media. J. Infect. Dis. 172:1995;115-118.
28. Sloyer J.L. Jr, Howie V.M., Ploussard J.H., Amman R., Austrian R., Johnston R.B. Jr. Immune response to acute otitis media in children. I. Serotypes isolated and serum and middle ear fluid antibody in pneumococcal otitis media. Infect. Immun. 9:1974;1028-1032.
29. Koskela M. Antibody response of young children to parenteral vaccination with pneumococcal capsular polysaccharides: a comparison between antibody levels in serum and middle ear effusion. Pediatr. Infect. Dis. J. 5:1986;431-434.
30. Virolainen A., Jero J., Käyhty H., Karma P., Leinonen M., Eskola J. Antibodies to pneumolysin and pneumococcal capsular polysaccharides in middle ear fluid of children with acute otitis media. Acta Otolaryngol. 115:1995;796-803.
31. Giebink G.S. The pathogenesis of pneumococcal otitis media in chinchillas and the efficacy of vaccination in prophylaxis. Rev. Infect. Dis. 3:1981;342-352.
32. Sloyer J.L. Jr, Howie V.M., Ploussard J.H., Schiffman G., Johnston R.B. Jr. Immune response to acute otitis media: association between middle ear fluid antibody and the clearing of clinical infection. J. Clin. Microbiol. 4:1976;306-308.
33. Nieminen T., Eskola J., Käyhty H. Pneumococcal conjugate vaccination in adults: circulating antibody secreting cell response and humoral antibody responses in saliva and in serum. Vaccine. 16:1998;630-636.
34. Koskela M. Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneuococcal otitis media or to vaccination. Pediatr. Infect. Dis. J. 6:1987;519-526.
35. Quataert S.A., Kirch C.S., Wiedl L.J., Phipps D.C., Strohmeyer S., Cimino C.O., Skuse J., Madore D.V. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, Lot 89-S. Clin. Diagn. Lab. Immunol. 2:1995;590-597.
36. Plaut A.G. The IgA1 proteases of pathogenic bacteria. Annu. Rev. Microbiol. 37:1983;603-622.
37. Kilian M., Mestecky J., Russell M.W. Defence mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Mircobiol. Rev. 52:1988;296-303.
38. Dagan R., Eskola J., Leroy O., Bailleux F. Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants. Infect. Immun. 66:1998;2093-2098.
39. Leinonen M., Säkkinen A., Kalliokoski R., Luotonen J., Timonen M., Mäkelä P.H. Antibody response to 14-valent pneumococcal capsular polysaccharide vaccine in preschool age children. Pediatr. Infect. Dis. J. 5:1986;39-44.
40. Mäkelä P.H., Karma P., Sipilä M., Pukander J., Leinonen M. Possibilities of preventing otitis media by vaccination. Scand. J. Infect. Dis. Suppl. 39:1983;34-38.
41. Van den Dobbelsteen G.P.J., Brunekreef K., Sminia T., Van Rees E.P. Effect of mucosal and systemic immunization with pneumococcal polysaccharide type 3, 4 and 14 in the rat. Scand. J. Immunol. 36:1992;661-669.
42. Svennerholm A.-M., Hanson L.Å., Holmgren J., Lindblad B.S., Nilsson B., Quereshi F. Different secretory immunoglobulin A antibody responses to cholera vaccination in Swedish and Pakistani Women. Infect. Immun. 30:1980;427-430.
43. Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretion. J. Clin. Immunol. 7:1987;265-276.
44. Kehrl J.H., Fauci A.S. Activation of human B lymphocytes after immunization with pneumococcal polysaccharides. J. Clin. Invest. 71:1983;1032-1040.
45. Lue C., Tarkowski A., Mestecky J. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies. J. Immunol. 140:1988;3793-3800.
46. Tarkowski A., Lue C., Moldoveanu Z., Kiyono H., McGhee J.R., Mestecky J. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses. J. Immunol. 144:1990;3770-3778.